Evaluation of Risk Factors Associated with Diabetic Foot Ulcers in Saudi Arabia

Author(s): Mousab Yousef Al-Ayed*, Mutasem Ababneh, Asirvatham Alwin Robert, Ahmed Salman, Abdulghani Al Saeed, Mohamed Abdulaziz Al Dawish

Journal Name: Current Diabetes Reviews

Volume 15 , Issue 3 , 2019

Become EABM
Become Reviewer
Call for Editor


Background and Aims: Considering that diabetic foot ulceration is one of the major health issues globally, we aimed to evaluate the risk factors associated with foot ulcers in patients with type 2 diabetes mellitus (T2DM).

Methods: A total of 81 T2DM patients (age range: 40-80 years) registered at the Diabetes Treatment Center, Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia between April and September 2015 were included in this cross-sectional study after purposive selection and assigning of patient numbers. The selected participants were interviewed and examined, and their medical records were reviewed for sensory, vibratory, and painful neuropathies; vascular insufficiency; retinopathy; and dermatological variations. The Wagner’s classification system was employed to evaluate the stage of patients’ foot ulcers.

Results: Among the study participants [mean age range: 56.4 ± 6.72 years; 53 males (65.4%)], cases of loss of protective sensation, foot deformity, amputation history, and dermatological abnormalities were notable. The Wagner gradation value of ulcers were grade 0 for 16% study population, grade 1 for 35.8%, grade 2 for 45.7%, grade 3 for 2.5%, and grades 4 and 5 for 0%. Approximately 19% of the patients had a previous case of amputation and 29.6% had nail disease. The most common footwear reported to be used by the patients was sandals shoes (46%).

Conclusion: The issues of loss of protective sensation, vascular insufficiency, deformity, previous amputations, and dermatological abnormalities of the lower limbs were found to be most common among the foot ulceration patients. The study findings thus recommend regular foot examination, following basic hygiene habits, encouragement of the use of appropriate footwear, patient education about foot ulcers, and prompt treatment for minor injuries to prevent further ulceration in DM patients.

Keywords: Diabetes complication, diabetic foot ulcer, risk factors, Saudi Arabia, dermatological, westernization.

Midhet FM, Al-Mohaimeed AA, Sharaf FK. Lifestyle related risk factors of type 2 diabetes mellitus in Saudi Arabia. Saudi Med J 2010; 31: 768-74.
Bacchus RA, Bell JL, Madkour M, Kilshaw B. The prevalence of diabetes mellitus in male Saudi Arabs. Diabetologia 1982; 23: 330-2.
Fatani HH, Mira SA, El-Zubier AG. Prevalence of diabetes mellitus in rural Saudi Arabia. Diabetes Care 1987; 10: 180-3.
Tryggestad JB, Willi SM. Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial. J Diabetes Complications 2015; 29(2): 307-12.
Sargen MR, Hoffstad O, Margolis DJ. Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations. J Diabetes Complications 2013; 27: 128-33.
Boulton AJ, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008; 31: 1679-85.
Shahbazian H, Yazdanpanah L, Latifi SM. Risk assessment of patients with diabetes for foot ulcers according to risk classification consensus of International Working Group on Diabetic Foot (IWGDF). Pak J Med Sci 2013; 29: 730-4.
Ndip EA, Tchakonte B, Mbanya JC. A study of the prevalence and risk factors of foot problems in a population of diabetic patients in cameroon. Int J Low Extrem Wounds 2006; 5: 83-8.
Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 1991; 13: 63-7.
Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002; 19: 377-84.
Frykberg RG, Armstrong DG, Giurini J, et al. Diabetic foot disorders: a clinical practice guideline. J Foot Ankle Surg 2000; 39: S1-S60.
AlAyed MY, Younes N, Al-Smady M, Khader YS, Robert AA, Ajlouni K. Prevalence of foot ulcers, foot at risk and associated risk factors among Jordanian diabetics. Curr Diabetes Rev 2017; 13(2): 182-91.
Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag 2007; 3: 65-76.
Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: Incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002; 19: 377-84.
Alexiadou K, Doupis J. Management of diabetic foot ulcers. Diabetes Ther 2012; 3: 4.
Centers for Disease C, Prevention. Lower extremity disease among persons aged > or =40 years with and without diabetes--United States, 1999-2002. Morbidity and mortality weekly report 2005; 54: 1158-60.
Lauterbach S, Kostev K, Kohlmann T. Prevalence of diabetic foot syndrome and its risk factors in the UK. J Wound Care 2010; 19: 333-7.
Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: A comparison of severity and outcome. Diabetes Care 2001; 24: 1433-7.
Vileikyte L, Rubin RR, Leventhal H. Psychological aspects of diabetic neuropathic foot complications: an overview. Diabetes Metab Res Rev 2004; 20(Suppl. 1): S13-8.
Lazzarini PA, Hurn SE, Fernando ME, et al. Prevalence of foot disease and risk factors in general inpatient populations: a systematic review and meta-analysis. BMJ Open 2015; 5: e008544.
Jia L, Parker CN, Parker TJ, et al. Incidence and risk factors for developing infection in patients presenting with uninfected diabetic foot ulcers. PLoS One 2017; 12: e0177916.
Rooh Ul M, Ahmed M, Griffin S. Evaluation and management of diabetic foot according to Wagner’s classification. A study of 100 cases. JAMC 2003; 15: 39-42.
Boulton AJ, Jude EB. Therapeutic footwear in diabetes: the good, the bad, and the ugly? Diabetes Care 2004; 27: 1832-3.
Knowles EA, Boulton AJ. Do people with diabetes wear their prescribed footwear? Diabet Med 1996; 13: 1064-8.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Published on: 16 August, 2018
Page: [224 - 232]
Pages: 9
DOI: 10.2174/1573399814666180816165848
Price: $65

Article Metrics

PDF: 54
PRC: 2